ASXL1 and acute myeloid leukemia: It has been reported that some somatic mutations, including ASXL1, BCOR, EZH2, SF3B1, SRSF2, STAG2, U2AF1, and ZRSR2 mutations are associated with an adverse prognosis of AML (12–14).